Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience
Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson’s disease
Tags: carbidopa/levodopa combination, catecholamine neurotransmitter precursor, dopamine precursor, Duopa®, epinephrine precursor, L-DOPA, norepinephrine precursor, Sinemet®
BASi Method Number SAP.1089
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
